Wouter J. de Waal

1.2k total citations · 1 hit paper
16 papers, 692 citations indexed

About

Wouter J. de Waal is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Wouter J. de Waal has authored 16 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Wouter J. de Waal's work include Sexual Differentiation and Disorders (5 papers), Growth Hormone and Insulin-like Growth Factors (4 papers) and Birth, Development, and Health (4 papers). Wouter J. de Waal is often cited by papers focused on Sexual Differentiation and Disorders (5 papers), Growth Hormone and Insulin-like Growth Factors (4 papers) and Birth, Development, and Health (4 papers). Wouter J. de Waal collaborates with scholars based in Netherlands, United Kingdom and United States. Wouter J. de Waal's co-authors include Sabine M.P.F. de Muinck Keizer‐Schrama, Stenvert L. S. Drop, T. Stijnen, Anita Hokken-Koelega, Kayleigh Arp, Marlies A. van Houten, Willem van Schaik, Marta Reyman, Rebecca L. Watson and Frans B. Plötz and has published in prestigious journals such as Nature Communications, PLoS ONE and Endocrine Reviews.

In The Last Decade

Wouter J. de Waal

15 papers receiving 670 citations

Hit Papers

Effects of early-life antibiotics on the developing infan... 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effects of early-life antibiotics on the developing infant gut microbiome and resistome: a randomized trial
    2022 185 citations Marta Reyman, Marlies A. van Houten et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wouter J. de Waal Netherlands 11 240 230 221 105 98 16 692
Ģirts Briģis Latvia 10 126 0.5× 178 0.8× 192 0.9× 244 2.3× 83 0.8× 22 695
Sudha Prasad India 16 98 0.4× 162 0.7× 69 0.3× 39 0.4× 189 1.9× 57 813
Johanna Metsälä Finland 12 145 0.6× 171 0.7× 28 0.1× 60 0.6× 126 1.3× 31 719
Dongxin Lin China 16 262 1.1× 211 0.9× 26 0.1× 58 0.6× 155 1.6× 55 864
Amina Barkat Morocco 19 91 0.4× 217 0.9× 35 0.2× 41 0.4× 190 1.9× 112 949
Alejandro Díaz United States 16 101 0.4× 65 0.3× 65 0.3× 43 0.4× 76 0.8× 60 615
J. H. Hoekstra Netherlands 22 105 0.4× 90 0.4× 235 1.1× 229 2.2× 48 0.5× 48 1.3k
Nazmul Islam Qatar 13 66 0.3× 77 0.3× 74 0.3× 22 0.2× 78 0.8× 56 639
Rasha Odeh Jordan 11 78 0.3× 101 0.4× 170 0.8× 147 1.4× 108 1.1× 35 506
Maria Micillo Italy 15 159 0.7× 78 0.3× 170 0.8× 161 1.5× 18 0.2× 20 987

Countries citing papers authored by Wouter J. de Waal

Since Specialization
Citations

This map shows the geographic impact of Wouter J. de Waal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter J. de Waal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter J. de Waal more than expected).

Fields of papers citing papers by Wouter J. de Waal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wouter J. de Waal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter J. de Waal. The network helps show where Wouter J. de Waal may publish in the future.

Co-authorship network of co-authors of Wouter J. de Waal

This figure shows the co-authorship network connecting the top 25 collaborators of Wouter J. de Waal. A scholar is included among the top collaborators of Wouter J. de Waal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wouter J. de Waal. Wouter J. de Waal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Corpeleijn, Willemijn E., Wouter J. de Waal, Henk S. Schipper, & Albert Wiegman. (2023). Dyslipidaemia as a target for atherosclerotic cardiovascular disease prevention in children with type 1 diabetes: lessons learned from familial hypercholesterolaemia. Diabetologia. 67(1). 19–26. 5 indexed citations
2.
Reyman, Marta, Marlies A. van Houten, Rebecca L. Watson, et al.. (2022). Effects of early-life antibiotics on the developing infant gut microbiome and resistome: a randomized trial. Nature Communications. 13(1). 893–893. 185 indexed citations breakdown →
3.
4.
Bruijning‐Verhagen, Patricia, Marie‐Josée J. Mangen, Nico G. Hartwig, et al.. (2013). Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination. BMC Medicine. 11(1). 112–112. 34 indexed citations
5.
Waal, Wouter J. de, et al.. (2011). Bacterial colonization patterns in neonates transferred from neonatal intensive care units. International Journal of Hygiene and Environmental Health. 214(2). 167–171. 10 indexed citations
6.
Waal, Wouter J. de, et al.. (2011). Klinische presentatie van kinderen met diabetes mellitus type 1 ten tijde van de diagnosestelling. Tijdschrift voor kindergeneeskunde. 79(1). 2–9. 1 indexed citations
7.
Houben, Michiel L., Peter G. J. Nikkels, Grada M. van Bleek, et al.. (2009). The Association between Intrauterine Inflammation and Spontaneous Vaginal Delivery at Term: A Cross-Sectional Study. PLoS ONE. 4(8). e6572–e6572. 65 indexed citations
8.
Waal, Wouter J. de, et al.. (2007). Enterobacter colonisation in newborn infants: predictors, follow-up and implications for infection control. Journal of Hospital Infection. 67(2). 142–148. 7 indexed citations
9.
Waal, Wouter J. de, et al.. (2005). Insulinepomptherapie bij de behandeling van diabetes mellitus type 1 bij kinderen. Tijdschrift voor kindergeneeskunde. 73(2). 210–214.
10.
Hokken‐Koelega, Anita C. S., Wouter J. de Waal, Theo Sas, Yvonne van Pareren, & Nicolette J. T. Arends. (2004). Small for gestational age (SGA): endocrine and metabolic consequences and effects of growth hormone treatment.. PubMed. 17 Suppl 3. 463–9. 23 indexed citations
11.
Drop, Stenvert L. S., Wouter J. de Waal, & Sabine M.P.F. de Muinck Keizer‐Schrama. (1998). Sex Steroid Treatment of Constitutionally Tall Stature*. Endocrine Reviews. 19(5). 540–558. 89 indexed citations
12.
Slijper, F.M.E., et al.. (1996). Poster Presentations (Part 7 of 9). Hormone Research in Paediatrics. 46(2). 88–100. 24 indexed citations
13.
Waal, Wouter J. de, et al.. (1996). Accuracy of final height prediction and effect of growth-reductive therapy in 362 constitutionally tall children.. The Journal of Clinical Endocrinology & Metabolism. 81(3). 1206–1216. 51 indexed citations
14.
Waal, Wouter J. de, et al.. (1995). Long term sequelae of sex steroid treatment in the management of constitutionally tall stature.. Archives of Disease in Childhood. 73(4). 311–315. 33 indexed citations
15.
Waal, Wouter J. de, J. T. M. Vreeburg, Frank C. Bekkering, et al.. (1995). High dose testosterone therapy for reduction of final height in constitutionally tall boys: does it influence testicular function in adulthood?. Clinical Endocrinology. 43(1). 87–95. 23 indexed citations
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ģirts Briģis Breakdown of academic impact, for papers by Sudha Prasad Breakdown of academic impact, for papers by Johanna Metsälä Breakdown of academic impact, for papers by Dongxin Lin Breakdown of academic impact, for papers by Amina Barkat Breakdown of academic impact, for papers by Alejandro Díaz Breakdown of academic impact, for papers by J. H. Hoekstra Breakdown of academic impact, for papers by Nazmul Islam Breakdown of academic impact, for papers by Rasha Odeh Breakdown of academic impact, for papers by Maria Micillo
Rankless by CCL
2026